Theranostic potential of a novel aptamer specifically targeting HER2 in breast cancer cells.
Fulya KucukcankurtSamet UcakNedret AltiokPublished in: Turkish journal of biology = Turk biyoloji dergisi (2024)
Our findings suggest that the novel DNA aptamer HMAP7 holds promise for both therapeutic and diagnostic applications, enabling selective delivery of therapeutic agents or imaging of HER2-positive breast tumors.